INSIGHTS ON CLINICAL TRIAL DESIGN
-
Investigator SmartSelect
This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.
-
Human-Centered RTSM Design Enhances Data, Safety, And Operations
Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
-
Clinical Leader Smart Sourcing Solutions Expo: Retention By Design
Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
Endpoint Clinical RTSM: Getting The Job Done
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
Use Data For Fit-For-Purpose Patient Recruitment Strategy10/29/2025
Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.
-
How To Improve Patient ID And Retention In Chronic Disease Trials4/23/2026
Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
-
Balancing Innovation, Ethics, and Operational Excellence in Adaptive Oncology Trials1/30/2025
Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.
-
Full Patient Journey Data A Must For Clinical Planning3/9/2026
Move beyond fragmented trial planning by using longitudinal patient insights to optimize protocols, improve site selection, and overcome recruitment hurdles for more predictable outcomes.
-
Inclusive Trial Design A 'Must-Have' In Modern R&D8/14/2025
Inclusivity in trial design is a crucial aspect of the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
-
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.